Connecting Research and Experts with Journalists

• share
• favorite_border

Today marks a significant milestone in cancer care with the introduction of bipartisan federal legislation that would revolutionize Medicare reimbursement for radiation therapy. The Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act of 2024, sponsored by Sen. Thom Tillis (R-N.C.) and by Reps. Brian Fitzpatrick (R-Pa.), Jimmy Panetta (D-Calif.) and Paul Tonko (D-N.Y.), would safeguard access to high quality cancer treatments for patients nationwide, improve patient outcomes and reduce health disparities while generating savings for Medicare. The Radiation Oncology Case Rate (ROCR) program shifts Medicare’s current per-treatment payment system to a more patient-centered approach.

• share
• favorite_border

Some proteins shift their shape when exposed to different temperatures, revealing previously unknown binding sites for medications.

• share
• favorite_border

A recent publication in the American Heart Association Circulation highlights the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.

• share
• favorite_border

• share
• favorite_border

A Memorial Hermann ER physician offers tips on how to avoid heat illness and dehydration this summer.

• share
• favorite_border

Fire ants form rafts to survive flooding, but how do those bonds work? And what can we learn from them? A Binghamton University, State University of New York professor is researching those questions to expand our knowledge of materials science.

• share
• favorite_border

Americans have gotten used to seeing their doctors and other health care providers using telehealth video visits. But a new study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care. The more professional, the better.

• share
• favorite_border

Lung cancer remains the leading cause of cancer-related deaths worldwide, with a significant portion of these deaths attributed to the aggressive nature of the disease and its resistance to traditional treatments. The study's findings offer a promising new avenue for therapeutic intervention by targeting the interaction between neutrophils and lung cancer cells, potentially improving patient outcomes.

• share
• favorite_border

According to a review published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer, certain combinations of medication or psychotherapy in conjunction with transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) are supported by clinical studies for treatment of major depressive disorder (MDD). The authors do caution that, overall, the research has important limitations.